We are live on ! Find out more
BCM

Bratton Capital Management Portfolio holdings

AUM $40.7M
1-Year Est. Return 43.1%
This Fund
S&P 500
This Quarter Est. Return
-30.9%
1 Year Est. Return
+43.1%
3 Year Est. Return
+264.04%
5 Year Est. Return
-20.19%
10 Year Est. Return
AUM
$68.1M
AUM Growth
-$33.5M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQST icon
1
Aquestive Therapeutics
AQST
$452M
$48.3M 70.95%
11,503,294
DNLI icon
2
Denali Therapeutics
DNLI
$3.79B
$19.8M 29.05%
953,035

Similar funds

Bratton Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Bratton Capital Management held 2 positions worth $68.1M, down 33% from $102M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 0%. Bratton Capital Management opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Bratton Capital Management's ten largest holdings make up 100% of its $68.1M portfolio in Q2 2019.
  • Bratton Capital Management opened 0 new positions and closed 0 in Q2 2019.
  • Bratton Capital Management's portfolio value fell 33% quarter-over-quarter to $68.1M.

Based on Bratton Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.